Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Average Recommendation of “Moderate Buy” from Brokerages

Posted by Brenda Bartman on Aug 19th, 2026

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $17.20.

Several brokerages recently issued reports on SENS. Mizuho reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 15th. Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 12th. Stifel Nicolaus lowered their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. HC Wainwright dropped their target price on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, May 12th. Finally, Wall Street Zen raised Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th.

Get Our Latest Report on SENS

Senseonics Holdings, Inc. Common Stock Trading Up 8.2%

Senseonics Holdings, Inc. Common Stock stock opened at $8.69 on Wednesday. The stock’s 50-day moving average is $5.99. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $11.58. The stock has a market cap of $363.24 million, a PE ratio of -3.90 and a beta of 1.01. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The firm had revenue of $14.48 million during the quarter. On average, equities analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current year.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Institutional investors and hedge funds have recently bought and sold shares of the stock. Stonepine Capital Management LLC purchased a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth approximately $276,502,000. Jefferies Financial Group Inc. purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at $102,000. Bank of America Corp DE purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at $2,241,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $65,000. Finally, Tocqueville Asset Management L.P. acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $315,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

About Senseonics Holdings, Inc. Common Stock

(Get Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.